ARTICLE | Clinical News
Basen voglibose regulatory update
December 24, 2007 8:00 AM UTC
Takeda submitted a Japanese marketing application to expand the label for Basen voglibose tablets 0.2 mg and Basen OD tablets 0.2 mg to prevent onset of Type II diabetes in patients with impaired gluc...